ArticleCureus2025
A Presentation of Fungating Nevoid Basal Cell Carcinoma Syndrome.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gorlin syndrome, also known as nevoid basal cell carcinoma syndrome (NBCCS), is a rare autosomal dominant disease marked by the development of numerous basal cell carcinomas (BCC) that tend to occur at young ages. Here the authors detail a case of a young adult Caucasian female with both a complex social and medical history. These social determinants of health played a significant role during her management and treatment plan. Although the patient had many eruptions of BCC throughout her body, one chronic, non-healing BCC lesion located amidst a shoulder wound would eventually turn into an ulcerative fungating mass, resulting in amputation of the left arm with recurrence of the BCC at the site of amputation. The patient's lesions were targeted with a combination of electrodessication and curettage (ED&C), Mohs surgery, and cemiplimab immunotherapy.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.